Interpreting elinzanetant data and benefits on sleep in postmenopausal women
In part 2 of our discussion with Fiona Baker, PhD, she details how to interpret data from the NIRVANA study, which revealed reductions in wakefulness after sleep onset in the elinzanetant group vs placebo.

▶︎
Spotlighting menopause and mental health with Jessica Gaulton, MD, MPH

▶︎
Fiona Baker, PhD, details elinzanetant's effectiveness on wakefulness after sleep onset

▶︎
What Mesothelioma Legal Questions Should I Ask?

▶︎
Stephanie Faubion, MD, MBA, on untangling sleep disorders from VMS in menopausal women

▶︎
Who are the Top Peritoneal Mesothelioma Doctors?

▶︎
She Asks if I Know Coldplay and This Singer Shocks The Street

▶︎
She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳

▶︎
How Hormones Shape Sexual Orientation & Behavior | Dr. Marc Breedlove

▶︎
300 Secret Historical Photos You Were Never Supposed to See

▶︎
NEVER Buy These 5 Types of Homes (I'm a Lawyer)

▶︎
HSDD screening in time-limited visits: Practical strategies for ob-gyns

▶︎
Pauline Maki, PhD, on why CBT for insomnia is underused in menopause care despite strong evidence

▶︎
Golden Retriever Meets Completely Broken Rescue for the First Time

▶︎
Better decision aids needed for individualized HRT counseling, expert argues

▶︎
Worst Plane Landing Fails Caught on Camera

▶︎
Learn English A1 to B2 in 4 Hours (Complete English Grammar Course for Beginners)

▶︎
PD Surgery for Mesothelioma: What Actually Happens?

▶︎
Vitamin D Expert: The Fastest Way To Dementia & The Big Lie About Sunlight!

▶︎
Spine Surgeon Drowns for 30 Minutes —Comes Back With a List

▶︎
